Monoclonal Antibody against HAAH
|
Indication:
|
Treatment
of hepatocellular carcinoma |
| Stage:
|
Preclinical
|
| First
Clinical Trial: |
2008
|
Monoclonal Antibody against HAAH - Toxin Conjugate
| Indication:
|
Treatment
of carcinoma of the bile duct |
| Stage:
|
Preclinical
|
| First
Clinical Trial: |
2008
|
PAN-811
| Indication:
|
Treatment
of Ischemic Stroke |
| Stage:
|
Preclinical
|
| First
Clinical Trial: |
Late
2007 or early 2008 |
|
